PFIZER
Back to Cashflow Statement
|
PFIZER Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-798 Cr | ₹-205 Cr | ₹-235 Cr | ₹-346 Cr | ₹-181 Cr |
What is the latest Cash Flow from Financing Activities ratio of PFIZER ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-798 Cr |
| Mar2025 | ₹-205 Cr |
| Mar2024 | ₹-235 Cr |
| Mar2023 | ₹-346 Cr |
| Mar2022 | ₹-181 Cr |
How is Cash Flow from Financing Activities of PFIZER Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-798 Cr | Negative | |
| Mar2025 | ₹-205 Cr | Negative | |
| Mar2024 | ₹-235 Cr | Negative | |
| Mar2023 | ₹-346 Cr | Negative | |
| Mar2022 | ₹-181 Cr | - | |
Compare Cash Flow from Financing Activities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹16,625.2 Cr | -0.1% | -5.8% | -29.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -0.1% |
-5.8% |
-29.5% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses